Llwytho...
Liver Bid-suppression for treatment of fibrosis associated with nonalcoholic steatohepatitis
BACKGROUND & AIMS: Liver fibrosis is the most worrisome feature of Nonalcoholic Steatohepatitis (NASH). Growing evidence supports a link between hepatocyte apoptosis and liver fibrogenesis. Our aim was to determine the therapeutic efficacy and safety of liver Bid, a key pro-apoptotic molecule, s...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Hepatol |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4761314/ https://ncbi.nlm.nih.gov/pubmed/26555271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2015.11.002 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|